Article and Video CATEGORIES

Cancer Journey

Search By

ABOUT
Denise Brock

Denise has over 30 years of varying experience in and out of the healthcare arena.  In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees.  She has grown with the organization and now oversees the operational movement of programs, efficiency and effectiveness within the organization, as well as the daily processes and functions.  

Lung Cancer Video Library - Spanish Language: Video #17 First Line Therapy for NSCLC Patients That Have Anaplastic Lymphoma Kinase (ALK) Positive
Thu, 01/05/2017 - 09:43
Terapia de primera línea para pacientes con cáncer pulmonar de células no pequeñas que presentan la cinasa de linfoma anaplásico (CLA) positiva.
Author
Denise Brock
 

For our 17th video in the GRACE Spanish Lung Cancer Library, Dr. Brian Hunis, Medical Director, Head and Neck Cancer Program, Memorial Cancer Institute, Miami, Florida, joined GRACE to discuss the basics of Lung Cancer for Spanish-speaking patients and caregivers.  In this video Dr. Hunis speaks about first line therapy for non-small cell lung cancer patients that have anaplastic lymphoma kinase (ALK) positive.

 


 

TRANSCRIPTS - Spanish and English
 

Terapia de primera línea para pacientes con cáncer pulmonar de células no pequeñas que presentan la cinasa de linfoma anaplásico (CLA) positiva.

En los pacientes en los cuales uno describe que el adenocarcinoma de pulmón de células no pequeñas tiene la translocación del gen ALK, hay terapia dirigida que atacan exclusivamente a las células que expresan esa mutación. Por lo cual los efectos adversos, la toxicidad y las respuestas son muchísimo mejores.

La primera terapia para pacientes con translocación en ALK que se ha usado en el mundo es con crisotinib. Crisotinib es una píldora que se toma diariamente, es bien tolerada y con efectos muy positivos.


First line therapy for non-small cell lung cancer patients that have the anaplastic lymphoma kinase positive.

In patients that have adenocarcinoma of non-small cells and also have the ALK gene translocation, there is a targeted treatment that only attacks the cell that express this mutation. So, the side effects, toxicity and the response are better.

The first therapy for patients with the ALK translocation that has been used in the world is with crisotinib. Crisotinib is a pill that is taken daily, is well tolerated and with very positive effects.

Video Language

Next Previous link

Previous PostNext Post

Related Content

Community Forum

Thought I should add that I am 65, former 30 yr smoker quit 8 yrs ago. Otherwise active and decent health. I will welcome any insight/answers to my questions whether to...

Hi and welcome to Grace,

I'm sorry you're going through this scare. I can't say if the 7mm growth in 7 years will or won't be a problem in the rather...

How does this forum work. Are community members able to reply to posts, or just moderators? Thanks

Usually the conversation is between the op and mod and/or faculty though we would like to have other members join in to share experiences, knowledge, and support. more heads are better...

Hi Michel, Welcome to Grace though I'm very sorry you are here.

Blood/liquid biopsies can detect cancer cells but usually only if there are a lot of cancer cells circulating. So...

Recent Comments

JOIN THE CONVERSATION
Usually the conversation is…
By JanineT Forum … on Wed, 01/19/2022 - 07:26
forum
By JanineT Forum … on Tue, 01/18/2022 - 19:22
Hi and welcome to Grace,
I'm…
By JanineT Forum … on Tue, 01/18/2022 - 13:46
me again
By JanineT Forum … on Tue, 01/18/2022 - 12:18